Stay updated with breaking news from ஸாட் ஷாகிர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers in the UK have assessed data from around the world to better understand the frequency and risk factors for myocarditis and pericarditis following immunization with messenger RNA (mRNA)-based vaccines designed to protect against coronavirus disease 2019 (COVID-19). ....
DSRU says more research needed to understand immunocompromised patients' responses to COVID-19 vaccines pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.
The DSRU is enrolling at least 15,000 patients who are then contacted at regular intervals after receiving the AstraZeneca vaccine, and asked whether they are experiencing any possible side effects. The study is one element of a series of measures to help protect the public, ensuring any adverse effects are quickly recognised and acted upon. It is expected that this proactive approach, sourcing information directly from vaccinees, will offer quicker and more thorough insight into any side effects or safety issues that arise with COVID-19 vaccines compared with other vaccine safety monitoring methods. Professor Saad Shakir, DSRU Director, said: “Creating new COVID-19 vaccines so quickly is a triumph for scientists. They have been subject to thorough evaluation of their efficacy and safety by the UK’s regulator, the MHRA. But the development process does not end now. Monitoring the safety and effectiveness of new products once they are being used in ‘real-life’ ....
The DSRU is enrolling at least 15,000 patients who are then contacted at regular intervals after receiving the AstraZeneca vaccine, and asked whether they are experiencing any possible side effects. The study is one element of a series of measures to help protect the public, ensuring any adverse effects are quickly recognised and acted upon. It is expected that this proactive approach, sourcing information directly from vaccinees, will offer quicker and more thorough insight into any side effects or safety issues that arise with COVID-19 vaccines compared with other vaccine safety monitoring methods. Professor Saad Shakir, DSRU Director, said: “Creating new COVID-19 vaccines so quickly is a triumph for scientists. They have been subject to thorough evaluation of their efficacy and safety by the UK’s regulator, the MHRA. But the development process does not end now. Monitoring the safety and effectiveness of new products once they are being used in ‘real-life’ ....